Suchergebnisse - "Goldstein, Larry B."

PubPharm (14)

1

Aggressive LDL-C Lowering and the Brain : Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association

enthalten in: Arteriosclerosis, thrombosis, and vascular biology | 2023

von Goldstein, L. | Toth, P. | Dearborn-Tomazos, J. | +6

ErratumIn: Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):e490. - PMID 37878679

2

Reply : Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond

enthalten in: Journal of the American College of Cardiology | 2020

von Szarek, M. | Amarenco, P. | Callahan, A. | +4

CommentOn: J Am Coll Cardiol. 2020 May 5;75(17):2110-2118. - PMID 32194196

3

Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories : The SPARCL Trial

enthalten in: Journal of the American College of Cardiology | 2020

von Szarek, M. | Amarenco, P. | Callahan, A. | +7

CommentIn: J Am Coll Cardiol. 2020 May 5;75(17):2119-2121. - PMID 32209335

4

Lipids in high-risk patients presenting with ischemic stroke or transient ischemic attack : are we missing the target?

enthalten in: Stroke | 2014

von Goldstein, L.

CommentOn: Stroke. 2014 Nov;45(11):3343-51. - PMID 25300975

5

Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial

enthalten in: Stroke | 2009

von Amarenco, P. | Goldstein, L. | Messig, M. | +7

6

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

enthalten in: Atherosclerosis | 2009

von Amarenco, P. | Goldstein, L. | Callahan, A. | +8

7

The complex relationship between cholesterol and brain hemorrhage

enthalten in: Circulation | 2009

von Goldstein, L.

CommentOn: Circulation. 2009 Apr 28;119(16):2136-45. - PMID 19364982

8

Relative and cumulative effects of lipid and blood pressure control in the stroke prevention by aggressive reduction in cholesterol levels trial

enthalten in: Stroke | 21 May 2009

von Amarenco, P. | Goldstein, L. | Messig, M. | +6

9

Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis : a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

enthalten in: Stroke | 2008

von Sillesen, H. | Amarenco, P. | Hennerici, M. | +6

10

Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack : the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

enthalten in: Stroke | 2007

von Amarenco, P. | Goldstein, L. | Szarek, M. | +8